published patent: FORMULATION OF ORAL COMPOSITIONS COMPRISING ARSENIC TRIOXIDE AND METHODS OF USE THEREOF

TitleFORMULATION OF ORAL COMPOSITIONS COMPRISING ARSENIC TRIOXIDE AND METHODS OF USE THEREOF
Priority Date2003-10-08 PCT/CN2003000843
2002-10-09 US 10/417200P
2003-06-25 US 10/483014P
Inventors
Issue Date2004
Citation
Australia Published Patent Application AU 2003271510. Australia: IP Australia, 2004 How to Cite?
AbstractThe present invention provides an oral formulation of arsenic trioxide (As2O3) for the treatment of a variety of hematological malignancies, including acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL). The present invention also prides methods for making the oral arsenic tioxide formulation. Methods of using the oral arsenic trioxide formulation are also described.
Persistent Identifierhttp://hdl.handle.net/10722/176542

 

DC FieldValueLanguage
dc.date.accessioned2012-11-30T08:38:06Z-
dc.date.available2012-11-30T08:38:06Z-
dc.date.issued2004-
dc.identifier.citationAustralia Published Patent Application AU 2003271510. Australia: IP Australia, 2004en_HK
dc.identifier.urihttp://hdl.handle.net/10722/176542-
dc.description.abstractThe present invention provides an oral formulation of arsenic trioxide (As2O3) for the treatment of a variety of hematological malignancies, including acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL). The present invention also prides methods for making the oral arsenic tioxide formulation. Methods of using the oral arsenic trioxide formulation are also described.en_HK
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documentsen_US
dc.titleFORMULATION OF ORAL COMPOSITIONS COMPRISING ARSENIC TRIOXIDE AND METHODS OF USE THEREOFen_HK
dc.typePatenten_US
dc.description.naturepublished_or_final_version-
dc.contributor.inventorCyrus, Rustam Kumanaen_HK
dc.contributor.inventorKwong, YLen_HK
patents.identifier.applicationAU 20030271510en_HK
patents.description.assigneeUNIV HONG KONGen_HK
patents.description.countryAustraliaen_HK
patents.date.publication2004-05-04en_HK
patents.date.application2003-10-08en_HK
patents.date.priority2003-10-08 PCT/CN2003000843en_HK
patents.date.priority2002-10-09 US 10/417200Pen_HK
patents.date.priority2003-06-25 US 10/483014Pen_HK
patents.description.ccAUen_HK
patents.identifier.publicationAU 2003271510en_HK
patents.relation.familyAU 2003271510 (A1) 2004-05-04en_HK
patents.relation.familyCN 1723029 (A) 2006-01-18en_HK
patents.relation.familyEP 1562616 (A2) 2005-08-17en_HK
patents.relation.familyJP 2006503109 (A) 2006-01-26en_HK
patents.relation.familyJP 4786341 (B2) 2011-10-05en_HK
patents.relation.familyUS 2004126434 (A1) 2004-07-01en_HK
patents.relation.familyUS 7521071 (B2) 2009-04-21en_HK
patents.relation.familyUS 2008085931 (A1) 2008-04-10en_HK
patents.relation.familyUS 2008089949 (A1) 2008-04-17en_HK
patents.relation.familyUS 2008089951 (A1) 2008-04-17en_HK
patents.relation.familyUS 2008166425 (A1) 2008-07-10en_HK
patents.relation.familyWO 2004032822 (A2) 2004-04-22en_HK
patents.relation.familyWO 2008046299 (A1) 2008-04-24en_HK
patents.relation.familyWO 2008046307 (A1) 2008-04-24en_HK
patents.description.kindA8en_HK
patents.typePatent_publisheden_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats